Zdrowie i gospodarka · 13/08/2018

FDA Announces Public Workshop to Inform Patient-Focused Drug Development Guidance

The FDA is hosting a 2-day public workshop to discuss methodological approaches for identifying patient priorities and selecting clinical outcome assessments for patient experience in clinical trials, informing the development of patient-focused drug development guidance required by the 21st Century Cures Act and PDUFA VI.